grant
saveGLYCYX MOR, INC. — A Phase 2 Trial of Axelopran Plus Pembrolizumab for the First-Line Treatment ...
community read0 votes
CA grant. $1,197,275. PI: LORIN K JOHNSON
view source ↗Data sources
last refreshed 5mo ago
Found something off?
CA grant. $1,197,275. PI: LORIN K JOHNSON
view source ↗
comments(0)
5-min edit window · permanent after that